The company will use the funds to grow its team and take the product to market in the Nordics, Germany and the UK.
Flow Neuroscience taps into an emerging field of treatment called TDCS (”transcranial direct current stimulation”) , which, many scientists believe, could help treat everything from learning disabilities to depression to stroke-related speech impairment.
“It’s a new way to think about depression treatment. We are adding a new tool in the toolkit for people suffering from depression,” Månsson, a trained clinical psychologist, says.
The company also supports users with an app that nudges them to sleep, eat and exercise better.
Full story:
more on the technology;